Company intelligence / Profile preview

BAG Diagnostics

Lich, Hessen, Germanybag-diagnostics.com ↗

Ownership: Private
Development stage: Commercial

Overview

BAG Diagnostics is a leading provider of in-vitro diagnostics specializing in immunological typing for transplantation and transfusion medicine. Their products include real-time PCR kits, HLA antibody detection platforms, and SSO-based molecular genetic analysis systems. They have a global presence with an export rate around 65%.

Therapeutic areas: ImmunologyHematology
Modalities: Diagnostic reagentsIn-vitro diagnostic systems
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on BAG Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BAG Diagnostics.

Explore the full profile